Related by context. All words. (Click for frequent words.) 85 mmHg 72 mm Hg systolic 72 systolic BP 72 mg dL 70 systolic blood pressure 68 mg dl 68 mmHg diastolic 67 mmHg systolic 67 systolic 67 #mmHg [001] 67 mm Hg diastolic 67 #/#mmHg 66 #mmHg [002] 66 diastolic blood pressure 66 HbA1c levels 66 diastolic BP 65 HbA 1c 65 mmol l 65 mL/min/#.# m 2 65 normotensive 64 diastolic pressure 63 mmol L 63 antihypertensive medications 63 LVEF 63 A1C levels 62 Hb A1C 62 pg mL 62 g dL 62 HbA1c 62 ng mL 62 #mm Hg 62 serum potassium 61 pulmonary capillary wedge 61 #.#/#.# mm Hg [002] 61 nmol L 61 ng ml 61 A1C 61 ng dL 60 PaO 2 60 proteinuria 60 #.#/#.# mmHg [001] 60 baseline HbA1c 60 -#.# mg dL [002] 60 creatinine clearance 60 systolic diastolic 60 hemoglobin A1c levels 60 diastolic blood pressures 60 LDL C 60 mL min 60 p = #.# [002] 60 mL kg 59 mEq L 59 g dl 59 fasting blood glucose 59 #.#/#.# mm Hg [001] 59 eGFR 59 binary restenosis 59 HbA1C 59 sUA 59 nicardipine 59 fasting plasma glucose 59 systolic pressure 59 fasting glucose 59 hypertensive patients 59 mg d 59 MADRS score 59 apnea hypopnea index 58 ejection fractions 58 P = .# 58 n = 58 #.#mmHg 58 serum phosphorus 58 glycated hemoglobin levels 58 systolic dysfunction 58 #mg/dL [002] 58 Diastolic 58 CI -#.# 58 ml min 58 CrCl 58 preoperatively 58 fasting plasma glucose FPG 58 oxygen saturation 58 lispro 58 intima media thickness 58 pmol L 58 nondiabetic patients 58 #mg/dL [001] 57 HbA 1c levels 57 nmol liter 57 mIU L 57 glycated hemoglobin 57 hemoglobin A1c HbA1c 57 systolic blood pressures 57 Systolic 57 diastolic 57 FEV1 57 creatinine ratio 57 #mg/dl 57 #.#/#.# mm Hg [003] 57 HbA1C levels 57 postop 57 left ventricular systolic 57 coronary revascularization 57 mg BID 57 creatinine levels 57 glomerular filtration rate 57 per deciliter mg 57 pg ml 56 A1c 56 mL/min/#.# m2 56 hypertensives 56 cholesterol LDL C 56 #.#mmol L [002] 56 plasma glucose levels 56 valsartan 56 arterial stiffness 56 tirofiban 56 glycated hemoglobin HbA1c 56 p = #.# [004] 56 x ULN 56 ng dl 56 postoperatively 56 serum uric acid 56 pulmonary arterial 56 hypertensive 56 μg mL 56 Intraocular pressure 56 antihypertensive therapy 56 prehypertension 56 placebo p 56 #.#ng/ml 56 fraction LVEF 56 aspartate aminotransferase AST 56 CDAI score 56 serum creatinine levels 56 mmol L. 56 titrated 56 A1c levels 56 % CI #.#-#.# [006] 56 ejection fraction 56 mmol 56 leukocyte count 56 p = 56 -#.# mm Hg 56 highest tertile 55 #.#mg/dL 55 serum phosphate levels 55 CK MB 55 nondiabetics 55 plasma glucose 55 % CI #.#-#.# [002] 55 confidence interval CI 55 mIU mL 55 fasting triglyceride levels 55 irbesartan 55 lipid levels 55 QTcF 55 supine systolic 55 mmHg p = 55 left ventricular ejection 55 mcg BID 55 infarct size 55 % CI #.#-#.# [003] 55 glycosylated hemoglobin HbA1c 55 NATRECOR R 55 mmol liter 55 prehypertensive 55 serum sodium 55 umol L 55 fasting glucose levels 55 glomerular filtration 55 nonfatal MI 55 interquartile range 55 hemoglobin A1C 55 mg TID 55 HOMA IR 54 lung function 54 hemoglobin A1c 54 nondiabetic 54 hip BMD 54 % CI #.#-#.# [004] 54 Diastolic pressure 54 nonobese 54 triglyceride levels 54 left ventricular dysfunction 54 aminotransferases 54 NNT = 54 hypertension 54 SBP DBP 54 alanine aminotransferase 54 index BMI 54 serum urate 54 diastolic pressures 54 microalbuminuria 54 cardiovascular mortality 54 myocardial infarction MI 54 hemoglobin concentrations 54 NSTE ACS 54 ± 54 troponin T 54 Cmax 54 kg/m2 54 DAS# [002] 54 lowest tertile 54 μmol L 54 periprocedural 54 CI #.#-#.# [001] 54 intraocular pressure 54 beta blocker therapy 54 preintervention 54 mcg mL 54 eptifibatide 54 asthma exacerbation 54 BENICAR 54 μg dL 54 myocardial infarction 54 oral antidiabetic medication 54 glycemia 54 % Confidence Interval 54 amlodipine 54 neutrophil counts 54 MMSE scores 54 allopurinol 54 baseline A1C 54 insulin detemir 54 kg m² 54 LV dysfunction 54 hemodynamic parameters 54 lumbar spine BMD 54 oxycodone CR 54 myocardial infarction stroke 54 target vessel revascularization 54 mU L 54 diameter stenosis 54 #mg/day [001] 53 psia 53 ATACAND 53 alanine aminotransferase ALT 53 #.#mmol l [002] 53 hypotension 53 IIIa inhibitors 53 cm H2O 53 ml kg 53 glimepiride 53 diuretic chlorthalidone 53 hsCRP levels 53 serum testosterone 53 intraocular pressure IOP 53 MMSE score 53 retinal thickness 53 unstable angina 53 iPTH 53 serum creatinine 53 abciximab 53 postprandial glucose 53 dyspnea 53 resistant hypertension 53 OGTT 53 arterial thromboembolic events 53 nmol 53 serum phosphorous 53 urinary albumin 53 serum concentrations 53 subclinical hypothyroidism 53 μg L 53 SpO 2 53 candesartan cilexetil 53 mg dose 53 albuminuria 53 angiotensin II receptor blockers 53 asymptomatic carotid stenosis 53 candesartan 53 -#.# mg dL [001] 53 ramipril 53 placebo 53 unfractionated heparin 53 NSTEMI 53 statin monotherapy 53 total cholesterol triglycerides 53 postprocedure 53 systolic diastolic blood 53 HbA 1C 53 -#.# mmHg 53 mEq 53 hypopneas 53 blood oxygen saturation 53 copies mL 53 fatal myocardial infarction 53 p = NS 53 angiotensin converting enzyme 53 echocardiographic 53 ropivacaine 53 PASI scores 53 mU liter 53 left ventricular hypertrophy 53 estimated glomerular filtration 53 #.#mmol L [001] 53 hemodynamics 53 Apgar scores 53 -#.# ± [001] 53 moderate renal impairment 53 achieved ACR# 53 PSA nadir 53 mg QD 53 recurrent VTE 53 Systolic blood pressure 53 coronary stenosis 53 p = .# [002] 53 nonfatal myocardial infarction 53 lopinavir r arm 53 incontinence episodes 53 severe exacerbations 53 log# copies mL 53 Complication rates 52 UA NSTEMI 52 nonfasting 52 serum cortisol 52 serum phosphate 52 diastolic hypertension 52 baseline serum creatinine 52 glycosylated hemoglobin 52 refractory ischemia 52 detemir 52 NIHSS score 52 urinary sodium excretion 52 Prehypertension 52 CRESTOR #mg 52 ug kg 52 mcg kg 52 angina chest 52 luminal diameter 52 NYHA class 52 EDSS score 52 Crohn Disease Activity 52 PCWP 52 acute coronary syndrome 52 thiazide diuretics 52 fasting insulin 52 serum glucose 52 serum triglycerides 52 mcg QD 52 reinfarction 52 ACE inhibitor perindopril 52 ventricular ejection fraction 52 LVSD 52 ≥ 52 UACR 52 HBeAg seroconversion 52 IRLS score 52 plasma concentrations 52 Baseline characteristics 52 repeat revascularization 52 LDL triglycerides 52 NPH insulin 52 NIHSS 52 sUA levels 52 platelet inhibition 52 mg tid 52 orthostatic 52 IIIa inhibitor 52 albumin excretion rate 52 posttransplant 52 abdominal circumference 52 plus GP IIb 52 systolic function 52 Hb A1c 52 pulmonary artery pressure 52 Apidra ® 52 placebo p = 52 preoperative 52 ABPM 52 methacholine challenge 52 elevated IOP 52 aspartate aminotransferase 52 REYATAZ r arm 52 oxygen desaturation 52 normal ULN 52 hemoglobin Hb 52 enoxaparin 52 OADs 52 postintervention 52 % CI #.#-#.# [007] 52 statistically significant p = 52 thromboembolic events 52 min -1 52 benazepril 52 ventricular mass 52 CDAI 52 primary aldosteronism 52 C reactive protein 52 hypokalemia 52 peak VO2 52 hours postdose 52 lowering systolic blood 52 BENICAR HCT 52 MACCE 51 arterial oxygen saturation 51 nonfatal stroke 51 Primary endpoints 51 serum urate levels 51 elevated creatinine 51 hypoglycemic events 51 urate lowering therapy 51 β blocker 51 creatinine 51 gastric pH 51 ejection fraction EF 51 antihypertensive medication 51 postoperative 51 nonfasting triglyceride levels 51 -#.# ± [002] 51 cerebral perfusion 51 HCTZ 51 mm Hg millimeters 51 β blockers 51 plasma triglycerides 51 SGRQ 51 hyperlipidaemia 51 total cholesterol LDL 51 mean baseline HbA1c 51 macular thickness 51 SGOT 51 copies ml 51 nonsignificant 51 microvascular complications 51 stable angina 51 urine albumin 51 confidence interval #.#-#.# 51 aldosterone antagonist 51 diastolic function 51 carotid IMT 51 renal function 51 hsCRP 51 glargine 51 distensibility 51 exhaled NO 51 systolic hypertension 51 kilopascals 51 log# IU mL 51 MBq 51 serum calcium 51 Montgomery Åsberg Depression 51 baseline Hb 51 Serum creatinine 51 IOP lowering 51 definite stent thrombosis 51 serum phosphorus levels 51 ‰ ¥ 51 left ventricular LV 51 abacavir lamivudine 51 flow mediated dilation 51 death reinfarction 51 systemic embolism 51 macrovascular 51 QRS duration 51 LV ejection fraction 51 log# 51 triacylglycerol concentrations 51 recurrent ischemia 51 cerebrovascular events 51 mL sec 51 % CI #.#-#.# [008] 51 peginterferon alfa 2a 51 mg BID dose 51 Taxus Stent 51 nanograms per 51 bypass grafting 51 sodium excretion 51 DASH diet 51 atheroma volume 51 endarterectomy 51 Left Ventricular Ejection Fraction 51 urinary albumin excretion 51 hypoxemia 51 serum triglyceride levels 51 QTc interval 51 patients undergoing CABG 51 serum magnesium 51 logMAR 51 antihypertensive agents 51 PREZISTA r arm 51 oxygen saturations 51 extrapyramidal symptoms 51 severe hypoglycemic 51 Fasting blood glucose 51 IPSS 51 oral antidiabetes 51 sd = 51 Index CDAI score 51 normothermic 51 6MWD 51 D dimer 51 detrusor 51 transaminases 51 NYHA functional class 51 serum potassium levels 51 #mg BID [003] 51 mineral density 51 #mg doses [002] 51 serum bilirubin 51 ACR Pedi 51 sodium nitroprusside 51 VT VF 51 #OHD levels 51 vasopressor 51 advanced adenoma 51 dapagliflozin plus 51 postoperative mortality 51 uncorrected visual acuity 51 mol L 51 detrusor overactivity 50 nmol l 50 transferrin saturation 50 renal dysfunction 50 lactate dehydrogenase LDH 50 salivary flow 50 mean baseline A1C 50 advanced adenomas 50 rehospitalization 50 postoperative complication 50 urinary oxalate 50 insulin glargine 50 pmol liter 50 albumin excretion 50 IOP 50 ischemic stroke 50 isolated systolic hypertension 50 posttreatment 50 reintervention 50 #mg/day [002] 50 dobutamine 50 anemia hemoglobin 50 fractional shortening 50 tertile 50 test OGTT 50 secondary endpoint 50 budesonide pMDI 50 plasma HCV RNA 50 triglycerides TG 50 SGPT 50 μg kg 50 serum IGF 50 mU 50 pulmonary function 50 Pred Forte 50 CK # plasma concentrations 50 serum TSH 50 triglyceride TG 50 revascularizations 50 mL 50 severe obstructive sleep 50 Index CDAI 50 phonophobia 50 noncardiovascular mortality 50 CI = 50 serum sodium concentration 50 pioglitazone 50 ACE inhibitor 50 angina 50 metformin monotherapy 50 Psoriasis Area 50 nonsignificant difference 50 thrombolytic therapy 50 serum cholesterol 50 anticoagulation 50 revascularization 50 nonfatal heart 50 Montgomery Asberg Depression 50 receiving ISENTRESS 50 carotid stenosis 50 statistical significance p 50 apnea hypopnea 50 clinically meaningful reductions 50 #ng/ml 50 lipid parameters 50 mg Lucentis 50 hemoglobin concentration 50 kPa 50 ACR# response 50 Fasting glucose 50 tolvaptan 50 4mg/kg 50 NT proBNP 50 antihypertensive drugs 50 LDL cholesterol levels 50 thyrotropin levels 50 adjunctive placebo 50 metoprolol tartrate 50 fasting serum 50 Secondary efficacy endpoints 50 uncontrolled hypertension 50 milligrams mg 50 nonobstructive CAD 50 -8 -9 50 Unified Parkinson Disease 50 p = .# [001] 50 methacholine 50 elevated LDL cholesterol 50 NovoLog ® Mix 50 intact parathyroid hormone 50 mg 50 mmHg p 50 blood glucose levels 50 echocardiographic parameters 50 nocturnal hypoglycaemia 50 mercury mmHg 50 certolizumab 50 glucose concentrations 50 mcg dL 50 biochemical recurrence 50 Triglyceride levels 50 MELD scores 50 nonfasting triglycerides 50 calculated creatinine clearance 50 Postoperative 50 diopters 50 ischemia driven 50 olmesartan 50 severe renal impairment 50 target lesion revascularization 50 kg -1 50 mild renal impairment 50 μg dose 50 OPCAB 50 silent ischemia 50 PRADAXA #mg 50 revascularization procedures 50 endometrial thickness 50 SELENA SLEDAI score 50 undetectable HBV DNA 50 hypoglycemia 50 tolterodine ER 50 ipsilateral 50 undetectable HCV RNA 49 preserved systolic 49 mg simvastatin 49 hydroxyvitamin D levels 49 residual platelet reactivity 49 undetectable viral load 49 CI #.#-#.# [002] 49 Visual Analogue Scale VAS 49 timepoints 49 corrected QT interval 49 composite endpoint 49 noncardiac surgery 49 p ≤ 49 dysfunction LVSD 49 p = #.# [003] 49 Ejection Fraction 49 inspiratory 49 nadolol 49 labetalol 49 bpm 49 active comparator 49 myocardial ischemia 49 decompensated heart failure 49 Atacand 49 aspirin beta blockers 49 mild renal insufficiency 49 #OHD 49 mg qd 49 LDL 49 atherogenic dyslipidemia 49 ipsilateral stroke 49 preserved ejection fraction 49 mIU ml 49 biphasic insulin aspart 49 PANSS total 49 depressive symptoms 49 sinus rhythm 49 μg d 49 macrovascular disease 49 hyperglycemia 49 Ishak fibrosis score 49 Scale cognitive subscale 49 ventilatory 49 systemic corticosteroid 49 mg kg Hematide 49 blood Phe levels 49 nonfatal myocardial infarction MI 49 symptomatic intracranial 49 HAM D# scores 49 % CI #.#-#.# [001] 49 #mg dose [003] 49 renal insufficiency 49 postoperative complications 49 annualized relapse 49 μg liter 49 placebo fluoxetine 49 aminotransferase levels 49 perioperative complications 49 natriuretic peptides 49 Fasting glucose levels 49 diastolic readings 49 EDSS scores 49 International Prostate Symptom 49 procalcitonin 49 -#.# mmol L 49 severe hypoglycemia 49 mg kg 49 evaluable subjects 49 tapentadol ER 49 overt nephropathy 49 TMC# r 49 nanomoles per 49 waist girth 49 HF hospitalization 49 mg kg dose 49 angiotensin converting enzyme inhibitor 49 macrovascular events 49 cGy 49 bezafibrate 49 cerebral infarction 49 elevated triglycerides 49 erythrocyte sedimentation rate 49 glulisine 49 acute coronary syndromes 49 ACE inhibitors 49 HAQ DI 49 atorvastatin #mg 49 arteriolar 49 racemic albuterol 49 chlorthalidone 49 dose atorvastatin 49 homocysteine levels 49 subcutaneous insulin 49 euthyroid 49 pooled comparator 49 metformin IR 49 Secondary endpoints 49 STEMI patients 49 ventricular function 49 serum lipid levels 49 elevated serum creatinine 49 cardiovascular hospitalizations 49 milliliters mL 49 aliskiren 49 haemorrhagic stroke 49 NYHA Class II 49 Left ventricular ejection 49 ertapenem 49 eplerenone 49 antihypertensives 49 achieving PASI 49 Forced expiratory volume 49 brachial blood 49 ug ml 49 confidence intervals CIs 49 μg dl 49 Thrombolysis 49 neurodevelopmental impairment 49 ischemic 49 RYGB 49 GERD symptom 49 symptom severity 49 virologic failure 49 colorectal adenoma 49 glycaemia 49 P ≤ 49 postdose 49 reflux symptoms 49 lipid lowering therapy 49 undergoing coronary angiography 49 lipid lowering agents 49 nitroprusside 49 Visual acuity 49 μg 49 lipid profiles 49 mm3 49 impaired fasting glucose 49 esomeprazole 49 HDRS 49 events MACE 49 Score DAS# 49 elevated ALT 49 macroalbuminuria 49 statistically significant p 49 NYHA Class III 49 thrombotic events 49 coronary heart 49 acute myocardial infarction AMI 49 Operative mortality 49 Key secondary endpoints 49 peptide BNP 49 laboratory abnormalities 49 gestational age 49 estimated GFR 49 blood glucose 49 brachial artery 49 morphometric vertebral fractures 49 stent binary restenosis 49 recurrent DVT 49 mercury mm Hg 49 XIENCE V PROMUS Stent 49 renal artery stenosis 49 cilostazol 49 mcg 49 coronary angiography 49 nasal obstruction 49 venous thrombosis 49 transthoracic 49 serum PTH 49 lispro alone 48 systemic corticosteroids 48 adjunctive ABILIFY 48 protein excretion 48 non valvular atrial 48 fluticasone salmeterol 48 left ventricular diastolic 48 HCV RNA 48 renal impairment 48 clinically meaningful improvements 48 International Normalized Ratio 48 #mg QD [002] 48 tertiles 48 comparator arm 48 Hb 48 liver histology 48 Knodell necroinflammatory score 48 inotropic agents 48 IU mL 48 ± SD 48 LS BMD 48 carotid intima media 48 sulphonylurea 48 serum HBV DNA 48 serum sodium levels 48 hs CRP 48 hypogonadal 48 Target Lesion Revascularization TLR 48 hyperemia 48 leukopenia 48 prolactin levels 48 pressure monitoring ABPM 48 diastolic dysfunction 48 hypotensive 48 pCR 48 mediated dilation 48 elevated uric acid 48 Fasting plasma glucose 48 secondary efficacy endpoint 48 Secondary endpoints included 48 ALT elevation 48 median PFS 48 microg 48 trough FEV1 48 somnolence headache 48 unfractionated heparin UFH 48 Hb levels 48 fondaparinux 48 intravascular volume 48 glycemic control 48 Lp PLA2 48 kidney function 48 afterload 48 orthostatic hypotension 48 atherosclerotic renal artery stenosis 48 brachial 48 plasma uric acid 48 pump CABG 48 titrated glipizide 48 acutely decompensated congestive heart 48 ischemic cardiomyopathy 48 BMI ≥ 48 T2DM 48 SpO2 48 quetiapine 48 endoscopic remission 48 TAXUS Express Stent 48 reintubation 48 kcal d 48 airflow obstruction 48 postprandial blood glucose 48 cardiovascular morbidity 48 adiponectin concentrations 48 revascularisation 48 postoperative morbidity 48 CC genotype 48 = #.#-#.# 48 apolipoprotein B 48 density lipoprotein cholesterol 48 perioperatively 48 spirometric 48 serum ALT 48 statin therapy 48 nmol L. 48 reperfusion 48 exhaled nitric oxide 48 lobectomy 48 cerebral oxygenation 48 oral hypoglycemic agents 48 cirrhotic patients 48 inhaled nitric oxide 48 hypophosphatemia 48 dual antiplatelet therapy 48 angiotensin converting enzyme ACE 48 hyperoxia 48 TURBT 48 ventricular tachyarrhythmia 48 paroxysmal AF 48 TIMI 48 CR nPR 48 platelet reactivity 48 thromboembolic 48 μg doses 48 inotropic 48 adenoma 48 femoral neck BMD 48 peak expiratory flow 48 DAS# remission 48 elevated fasting glucose 48 Cardiopulmonary bypass 48 achieved statistical significance 48 paricalcitol 48 recurrent venous thromboembolism 48 mCi kg 48 hyperphenylalaninemia HPA due 48 Lucentis monotherapy 48 ADCS ADL 48 cTnT levels 48 IU ml 48 deep venous thromboses 48 BYSTOLIC 48 ALLHAT 48 oral glucose tolerance 48 undergoing coronary artery 48 telmisartan 48 corrected visual acuity 48 LDL cholesterol 48 LANTUS R 48 plasma folate 48 Lantus ® 48 primary efficacy endpoint 48 hyperkalemia 48 DAPT 48 infarction NSTEMI 48 ug mL 48 serum calcium levels 48 creatine phosphokinase 48 corneal curvature 48 plasma lipids 48 Kaplan Meier analysis 48 sweat chloride 48 Postoperatively 48 recurrent atrial fibrillation 48 losartan 48 virologic response 48 lipid lowering medications 48 mg RDEA# 48 UPDRS 48 GnRH agonist 48 SCr 48 nondepressed 48 PSADT 48 intermittent hemodialysis 48 Monitoring ABPM 48 postoperative bleeding 48 NHANES III 48 BMI #-#.# 48 achieved PASI 48 AUC0 48 tipranavir r 48 cerebrovascular accident 48 μmol l 48 triglyceride concentrations 48 UPDRS scores 48 plasma renin 48 oral prednisone 48 sinus tachycardia 48 Ambulatory Blood Pressure 48 failure TVF 48 MADRS 48 AST ALT 48 acute STEMI 48 abdominal pain flatulence 48 maximally tolerated doses 48 diastolic heart 48 WOMAC pain 48 aminotransferase elevations greater 48 basal bolus therapy 48 albumin creatinine ratio 48 bypass graft CABG surgery 48 lopinavir r 48 Fonarow 48 uM 48 fibrinolytic therapy 48 rizatriptan 48 hypopnea 48 alteplase 48 hypovolemic 48 Rating Scale MADRS 48 ETDRS 48 CYPHER Stent 48 nadroparin 48 baseline FEV 48 serum leptin 48 plasma homocysteine 48 waist circumference 48 μg ml